62 related articles for article (PubMed ID: 15272226)
41. Rakicidin A: a hypoxia-selective cytotoxin.
Yamazaki Y; Kunimoto S; Ikeda D
Biol Pharm Bull; 2007 Feb; 30(2):261-5. PubMed ID: 17268062
[TBL] [Abstract][Full Text] [Related]
42. Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells.
Lee PWT; Koseki LR; Haitani T; Harada H; Kobayashi M
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730681
[TBL] [Abstract][Full Text] [Related]
43. Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.
Cao J; Zhang Z; Zhou L; Luo M; Li L; Li B; Nice EC; He W; Zheng S; Huang C
MedComm (2020); 2023 Dec; 4(6):e427. PubMed ID: 38045829
[TBL] [Abstract][Full Text] [Related]
44. Hypoxia in the Initiation and Progression of Neuroblastoma Tumours.
Huertas-Castaño C; Gómez-Muñoz MA; Pardal R; Vega FM
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861671
[TBL] [Abstract][Full Text] [Related]
45. New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence.
Schor NF
Pharmacol Ther; 2009 Apr; 122(1):44-55. PubMed ID: 19318043
[TBL] [Abstract][Full Text] [Related]
46. Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1α and P-gp in the human pancreatic carcinoma cell line PANC-1.
Zhu Z; Wang Y; Liu Z; Wang F; Zhao Q
Oncol Rep; 2012 May; 27(5):1567-72. PubMed ID: 22367292
[TBL] [Abstract][Full Text] [Related]
47. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
[TBL] [Abstract][Full Text] [Related]
48. [Role of hypoxia-inducible factor-1alpha in the prevention of cardiomyocyte injury induced by hypoxic preconditioning].
Xu FF; Liu XH; Cai LR
Sheng Li Xue Bao; 2004 Oct; 56(5):609-14. PubMed ID: 15497042
[TBL] [Abstract][Full Text] [Related]
49. Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells.
Thomas R; Kim MH
Biochem Biophys Res Commun; 2005 Aug; 334(2):543-8. PubMed ID: 16005427
[TBL] [Abstract][Full Text] [Related]
50. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
51. Hypoxia-inducible factor 1alpha- mediated resistance to phenolic anticancer.
Hyun JY; Chun YS; Kim TY; Kim HL; Kim MS; Park JW
Chemotherapy; 2004 Jun; 50(3):119-26. PubMed ID: 15272226
[TBL] [Abstract][Full Text] [Related]
52. [Regulation of hypoxia-inducible factor-1alpha expression].
Du KM; Chen GQ; Chen Z
Ai Zheng; 2004 Sep; 23(9):1098-102. PubMed ID: 15363211
[TBL] [Abstract][Full Text] [Related]
53. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances.
Surh Y
Mutat Res; 1999 Jul; 428(1-2):305-27. PubMed ID: 10518003
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
